MedPath

VENCLEXTA

VENCLEXTA

Approved
DIN Number

02458039

Drug Class

Human

Market Date

Oct 31, 2016

Company
HC

Abbvie Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02458039
AIG Number0158490001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XX52 VENETOCLAX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VENETOCLAXActive
Strength: 10 MG
Monograph: VENETOCLAX

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.